{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:21:20Z","timestamp":1793521280251,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08971-7","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T07:49:19Z","timestamp":1752306559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reduced rates of diabetic retinopathy complications with use of continuous glucose monitoring"],"prefix":"10.1038","volume":"15","author":[{"given":"Amer F.","family":"Alsoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euna","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eubee","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithvi","family":"Mruthyunjaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Rahimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"issue":"1","key":"8971_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","volume":"2","author":"R Lee","year":"2015","unstructured":"Lee, R., Wong, T. Y. & Sabanayagam, C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis. 2 (1), 17. https:\/\/doi.org\/10.1186\/s40662-015-0026-2 (2015).","journal-title":"Eye Vis."},{"key":"8971_CR2","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes\u20142024. Diabetes Care. ;47(Supplement_1):S231-S243. (2023). https:\/\/doi.org\/10.2337\/dc24-S012","DOI":"10.2337\/dc24-S012"},{"issue":"14","key":"8971_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"Diabetes Control and Complications Trial Research Group et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl. J. Med. 329 (14), 977\u2013986. https:\/\/doi.org\/10.1056\/NEJM199309303291401 (1993).","journal-title":"N Engl. J. Med."},{"issue":"8","key":"8971_CR4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"The relationship of","year":"1995","unstructured":"The relationship of. Glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44 (8), 968\u2013983 (1995).","journal-title":"Diabetes"},{"issue":"4","key":"8971_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4093\/dmj.2015.39.4.273","volume":"39","author":"S Suh","year":"2015","unstructured":"Suh, S. & Kim, J. H. Glycemic variability: how do we measure it and why is it important?? Diabetes Metab. J. 39 (4), 273\u2013282. https:\/\/doi.org\/10.4093\/dmj.2015.39.4.273 (2015).","journal-title":"Diabetes Metab. J."},{"issue":"7","key":"8971_CR6","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1097\/IAE.0000000000003049","volume":"41","author":"JY Park","year":"2021","unstructured":"Park, J. Y. et al. Retina Phila. Pa. ;41(7):1487\u20131495. doi:https:\/\/doi.org\/10.1097\/IAE.0000000000003049 (2021).","journal-title":"Retina Phila. Pa."},{"issue":"8","key":"8971_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc17-0636","volume":"40","author":"RW Beck","year":"2017","unstructured":"Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M. & Bergenstal, R. M. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care. 40 (8), 994\u2013999. https:\/\/doi.org\/10.2337\/dc17-0636 (2017).","journal-title":"Diabetes Care"},{"key":"8971_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fnins.2019.00458","volume":"13","author":"YR Lai","year":"2019","unstructured":"Lai, Y. R. et al. HbA1C variability is strongly associated with the severity of cardiovascular autonomic neuropathy in patients with type 2 diabetes after longer diabetes duration. Front. Neurosci. 13, 458. https:\/\/doi.org\/10.3389\/fnins.2019.00458 (2019).","journal-title":"Front. Neurosci."},{"issue":"6","key":"8971_CR9","doi-asserted-by":"publisher","first-page":"e2221","DOI":"10.1210\/clinem\/dgac034","volume":"107","author":"M Yapanis","year":"2022","unstructured":"Yapanis, M., James, S., Craig, M. E., O\u2019Neal, D. & Ekinci, E. I. Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring. J. Clin. Endocrinol. Metab. 107 (6), e2221\u2013e2236. https:\/\/doi.org\/10.1210\/clinem\/dgac034 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"8971_CR10","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.2337\/dc18-1131","volume":"41","author":"J Lu","year":"2018","unstructured":"Lu, J. et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care. 41 (11), 2370\u20132376. https:\/\/doi.org\/10.2337\/dc18-1131 (2018).","journal-title":"Diabetes Care"},{"issue":"6","key":"8971_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/eye.2016.48","volume":"30","author":"MS Stem","year":"2016","unstructured":"Stem, M. S. et al. Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus. Eye Lond. Engl. 30 (6), 825\u2013832. https:\/\/doi.org\/10.1038\/eye.2016.48 (2016).","journal-title":"Eye Lond. Engl."},{"key":"8971_CR12","doi-asserted-by":"publisher","unstructured":"Almurashi, A. M., Rodriguez, E. & Garg, S. K. Emerging diabetes technologies: continuous glucose monitors\/artificial pancreases. J. Indian Inst. Sci. Published Online March 28, 2023:1\u201326. https:\/\/doi.org\/10.1007\/s41745-022-00348-3","DOI":"10.1007\/s41745-022-00348-3"},{"key":"8971_CR13","unstructured":"Commissioner O of the. FDA Clears First Over-the-Counter Continuous Glucose Monitor. FDA. Published March 6, 2024. Accessed May 3. (2024). https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-over-counter-continuous-glucose-monitor"},{"issue":"3","key":"8971_CR14","doi-asserted-by":"publisher","first-page":"e240728","DOI":"10.1001\/jamanetworkopen.2024.0728","volume":"7","author":"TYA Liu","year":"2024","unstructured":"Liu, T. Y. A. et al. Use of diabetes technologies and retinopathy in adults with type 1 diabetes. JAMA Netw. Open. 7 (3), e240728. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.0728 (2024).","journal-title":"JAMA Netw. Open."},{"issue":"23","key":"8971_CR15","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1001\/jama.2020.6940","volume":"323","author":"LM Laffel","year":"2020","unstructured":"Laffel, L. M. et al. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: A randomized clinical trial. JAMA 323 (23), 2388\u20132396. https:\/\/doi.org\/10.1001\/jama.2020.6940 (2020).","journal-title":"JAMA"},{"issue":"4","key":"8971_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jama.2016.19976","volume":"317","author":"M Lind","year":"2017","unstructured":"Lind, M. et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 317 (4), 379\u2013387. https:\/\/doi.org\/10.1001\/jama.2016.19976 (2017).","journal-title":"JAMA"},{"issue":"4","key":"8971_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck, R. W. et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317 (4), 371\u2013378. https:\/\/doi.org\/10.1001\/jama.2016.19975 (2017).","journal-title":"JAMA"},{"issue":"6","key":"8971_CR18","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.2337\/dc20-1690","volume":"44","author":"R Roussel","year":"2021","unstructured":"Roussel, R. et al. Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in france: the RELIEF study. Diabetes Care. 44 (6), 1368\u20131376. https:\/\/doi.org\/10.2337\/dc20-1690 (2021).","journal-title":"Diabetes Care"},{"issue":"22","key":"8971_CR19","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1001\/jama.2021.6530","volume":"325","author":"AJ Karter","year":"2021","unstructured":"Karter, A. J., Parker, M. M., Moffet, H. H., Gilliam, L. K. & Dlott, R. Association of Real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with Insulin-Treated diabetes. JAMA 325 (22), 2273\u20132284. https:\/\/doi.org\/10.1001\/jama.2021.6530 (2021).","journal-title":"JAMA"},{"issue":"10","key":"8971_CR20","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke, J. P. et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLOS Med. 4 (10), e297. https:\/\/doi.org\/10.1371\/journal.pmed.0040297 (2007).","journal-title":"PLOS Med."},{"issue":"7258","key":"8971_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton, I. M. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (7258), 405\u2013412. https:\/\/doi.org\/10.1136\/bmj.321.7258.405 (2000).","journal-title":"BMJ"},{"key":"8971_CR22","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes\u20142024. Diabetes Care. ;47(Supplement_1):S111-S125. (2023). https:\/\/doi.org\/10.2337\/dc24-S006","DOI":"10.2337\/dc24-S006"},{"issue":"7","key":"8971_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/dia.2020.0236","volume":"22","author":"C Fabris","year":"2020","unstructured":"Fabris, C., Heinemann, L., Beck, R., Cobelli, C. & Kovatchev, B. Estimation of hemoglobin A1c from continuous glucose monitoring data in individuals with type 1 diabetes: is time in range all we need?? Diabetes Technol. Ther. 22 (7), 501\u2013508. https:\/\/doi.org\/10.1089\/dia.2020.0236 (2020).","journal-title":"Diabetes Technol. Ther."},{"issue":"5","key":"8971_CR24","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00125-009-1304-0","volume":"52","author":"EM Horv\u00e1th","year":"2009","unstructured":"Horv\u00e1th, E. M. et al. Rapid glycaemic swings induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia 52 (5), 952\u2013961. https:\/\/doi.org\/10.1007\/s00125-009-1304-0 (2009).","journal-title":"Diabetologia"},{"issue":"1","key":"8971_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-018-0677-0","volume":"17","author":"CRL Cardoso","year":"2018","unstructured":"Cardoso, C. R. L., Leite, N. C., Moram, C. B. M. & Salles, G. F. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study. Cardiovasc. Diabetol. 17 (1), 33. https:\/\/doi.org\/10.1186\/s12933-018-0677-0 (2018).","journal-title":"Cardiovasc. Diabetol."},{"key":"8971_CR26","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Medical Care in Diabetes\u20142022. Diabetes Care. ;45(Supplement_1):S97-S112. (2021). https:\/\/doi.org\/10.2337\/dc22-S007","DOI":"10.2337\/dc22-S007"},{"key":"8971_CR27","doi-asserted-by":"publisher","unstructured":"Misso, M. L., Egberts, K. J., Page, M., O\u2019Connor, D. & Shaw, J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst. Rev. (1), CD005103. https:\/\/doi.org\/10.1002\/14651858.CD005103.pub2 (2010).","DOI":"10.1002\/14651858.CD005103.pub2"},{"issue":"12","key":"8971_CR28","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1007\/s00125-012-2708-9","volume":"55","author":"T Battelino","year":"2012","unstructured":"Battelino, T. et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55 (12), 3155\u20133162. https:\/\/doi.org\/10.1007\/s00125-012-2708-9 (2012).","journal-title":"Diabetologia"},{"issue":"3","key":"8971_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00592-013-0459-9","volume":"50","author":"G Sartore","year":"2013","unstructured":"Sartore, G., Chilelli, N. C., Burlina, S. & Lapolla, A. Association between glucose variability as assessed by continuous glucose monitoring (continuous glucose monitoring) and diabetic retinopathy in type 1 and type 2 diabetes. Acta Diabetol. 50 (3), 437\u2013442. https:\/\/doi.org\/10.1007\/s00592-013-0459-9 (2013).","journal-title":"Acta Diabetol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08971-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:13:47Z","timestamp":1757225627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08971-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8971"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08971-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25215"}}